Skip to main content

ORIGINAL RESEARCH article

Front. Microbiol.
Sec. Microorganisms in Vertebrate Digestive Systems
Volume 15 - 2024 | doi: 10.3389/fmicb.2024.1393732
This article is part of the Research Topic Early-life Gut Microbiota Perturbations and its Impacts on Host Health and Disease: From Underlying Mechanisms to Therapeutic Opportunities View all 3 articles

Priority order of the neonatal colonization by probiotic or pathogenic Escherichia coli strain dictates the host response to the experimental colitis

Provisionally accepted
  • 1 Laboratory of Gnotobiology, Institute of Microbiology of the Czech Academy of Sciences, Novy Hradek, Czechia
  • 2 Laboratory of Gnotobiology, Institute of Microbiology of the Czech Academy of Sciences,, Novy Hradek, Czechia
  • 3 Laboratory of Molecular Structure Characterization, Institute of Microbiology of the Czech Academy of Sciences, Prague, Prague, Czechia
  • 4 Laboratory of Gnotobiology, Institute of Microbiology of the Czech Academy of Sciences, Novy Hradek, Czech Republic, Novy Hradek, Czechia

The final, formatted version of the article will be published soon.

    The alarming prevalence of inflammatory bowel disease (IBD) already in early childhood is associated with imbalances in the microbiome, the immune response and environmental factors. Some pathogenic Escherichia (E.) coli strains have been found in IBD patients, where they may influence the progression of the disease. Therefore, the discovery of new harmful bacterial strains that have the potential to drive the inflammatory response is of great importance. In this study, we compared the immunomodulatory properties of two E. coli strains of serotype O6, the probiotic E. coli Nissle 1917 and the uropathogenic E. coli O6:K13:H1. Using the epithelial Caco-2 cell line, we investigated the different abilities of the strains to adhere to and invade epithelial cells. We confirmed the potential of E. coli Nissle 1917 to modulate the Th1 immune response in a specific manner in in vitro setting by stimulating mouse bone marrow-derived dendritic cells. In gnotobiotic in vivo experiments, we demonstrated that neonatal colonization with E. coli Nissle 1917 reaches a stable high concentration in the intestine and protects mice from the progressive effect of E. coli O6:K13:H1 on the development of ulcerative colitis in an experimental model. In contrast, single-dose treatment with E. coli Nissle 1917 is inefficient to achieve such a high concentration and does not protect against the development of DSS-induced ulcerative colitis in mice neonatally colonized with pathobiont E. coli O6:K13:H1. Despite the stable coexistence of both E. coli strains in the intestinal environment of the mice, we demonstrated a beneficial competitive interaction between the early colonizing E. coli Nissle 1917 and the late-arriving strain O6:K13:H1, suggesting its anti-inflammatory potential for the host. This study highlights the importance of the sequence of bacterial colonization, which influences the development of the immune response in the host gut and potentially impacts future quality of life.

    Keywords: Escherichia coli, priority effect, DSS-experimental colitis, mouse model, Immune Modulation

    Received: 29 Feb 2024; Accepted: 18 Jul 2024.

    Copyright: © 2024 Hudcovic, Petr Hermanova, Kozakova, Benada, Kofronova, Schwarzer and Srutkova. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Tomas Hudcovic, Laboratory of Gnotobiology, Institute of Microbiology of the Czech Academy of Sciences, Novy Hradek, Czechia
    Dagmar Srutkova, Laboratory of Gnotobiology, Institute of Microbiology of the Czech Academy of Sciences, Novy Hradek, Czech Republic, Novy Hradek, Czechia

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.